Answers are grounded in this paper and cite their sources.
The latest threat in multidrug resistance in Gram-negative bacteria corresponds to the emergence of NDM-1-producing isolates that have been identified in several countries worldwide. The plasmid-mediated blaNDM-1 gene encodes a metallo-β-lactamase (MBL) with high carbapenemase activity and was first identified in Escherichia coli and Klebsiella pneumoniae in Sweden from a patient transferred from India (14). It was later identified in different enterobacterial species from a series of patients in the United Kingdom, India, and Pakistan (8) and also from Australian and U.S. patients (3, 12).
No takes yet. Share an insight, caveat, or question.
Poirel et al. (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: